Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych CASC / OSCEPsychopharmacology — monoamine oxidase inhibitors

Psych CASC / OSCE · Psychopharmacology — monoamine oxidase inhibitors

Explaining MAOI diet, washouts and patch options (CASC)

CASC-style communication station: shared decision on classic MAOI versus selegiline patch, practical tyramine teaching, washouts, and absolute drug bans without terror or false reassurance.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 45-year-old professional with treatment-resistant depression and atypical features is offered phenelzine. She is frightened by 'cheese crisis' stories online, asks whether the selegiline patch is safer, and wonders if she can keep using tramadol for migraines and cold-and-flu tablets in winter.

Station instructions (candidate)

You have 7 minutes. Explain why an MAOI is being considered after multiple failed antidepressants, what the tyramine diet means in practical language, which medicines are absolute no-list items (including tramadol and many cold remedies), and how the selegiline patch differs on diet rules at 6 mg/24 h versus higher doses. Balance hope from TRD/atypical-depression evidence with honest safety requirements. Do not guarantee cure. Do not dismiss fear. Offer written materials and follow-up.[1][2][3][6]

Marking domains

Agenda setting and empathy; accurate plain-language explanation of why MAOIs can help when other tablets have not; practical high-tyramine food teaching (not endless folklore bans); clear absolute drug bans including tramadol and dextromethorphan-containing cold remedies; selegiline patch diet nuance without claiming zero interaction risk; washout concept if switching from current serotonergic medicines; collaborative plan, pharmacy alert, crisis contacts for severe headache after restricted food.[1][2][4][5]

Model communication map

  1. Open: thank her; check understanding of previous trials; name shared goals (mood recovery, work function, safety).[1]
  2. Why MAOI now: several proper antidepressant pathways have not led to remission; for some people with treatment-resistant or atypical symptom patterns, MAOIs remain an evidence-supported specialist option.[1][6]
  3. Diet without terror: a short list of high-risk aged/fermented/spoiled foods and draft beer — not a ban on all enjoyable eating; written card; storage matters.[2]
  4. Medicine red lines: no SSRI combinations; no tramadol; careful with cold-and-flu products; always check with pharmacy/doctor first.[5][1]
  5. Patch option: selegiline skin patch has trial evidence in depression; at the lowest 6 mg/24 h strength many protocols relax routine tyramine diet, but higher strengths put diet rules back on, and dangerous drug combinations still apply at every dose. Availability varies by country.[3][4]
  6. Washouts: if still on a serotonergic tablet, there is a planned gap (about two weeks for many agents; longer after fluoxetine) before a classic MAOI — safety, not bureaucracy.[1]
  7. Close: questions, written diet/drug list, who to call for sudden severe headache, next review, consent check.[2]

Common fails

  • Saying "just avoid all cheese forever" without practical nuance or written plan.[2]
  • Allowing tramadol or cold remedies "if the diet is good".[5]
  • Claiming the patch has no interactions at 12 mg/24 h.[4]
  • Guaranteeing remission or terrifying the patient into refusing without discussing benefits.[1]

References

  1. [1]Van den Eynde V, Abdelmoemin WR, Abraham MM, et al. The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr, 2023.PMID 35837681
  2. [2]Van den Eynde V, Gillman PK, Blackwell BB The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles Psychopharmacol Bull, 2022.PMID 35721816
  3. [3]Bodkin JA, Amsterdam JD Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients Am J Psychiatry, 2002.PMID 12411221
  4. [4]Amsterdam JD A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder J Clin Psychiatry, 2003.PMID 12633131
  5. [5]Gillman PK Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity Br J Anaesth, 2005.PMID 16051647
  6. [6]Liebowitz MR, Quitkin FM, Stewart JW, et al. Antidepressant specificity in atypical depression Arch Gen Psychiatry, 1988.PMID 3276282